Taken together, our findings revealed a subcellular event in which most of the p53null ovarian cancer cells stay longer in the G2/M phase of the cell cycle and attain more stemness-like features when they acquire resistance to carboplatin than p53-expressing ovarian cancer cells. The gene discussed is TP53; the disease is ovarian carcinoma.